Cj. Workman et Ew. Voss, Interaction of dual-specific autoantibodies with dsDNA and a synthetic dimer peptide simulating the hinge region of IgG2a molecules, MOL IMMUNOL, 37(15), 2000, pp. 931-939
Anti-dsDNA autoantibodies and immune complex formation are major factors in
SLE pathogenesis. Understanding stable immune complex formation is critica
l in deciphering mechanisms of autoimmune pathogenesis. Previous studies id
entified a subpopulation of murine lupus monoclonal autoantibodies that exh
ibited dual specificity (anti-DNA and anti-IgG2a hinge) and formed stable i
mmune complexes [J. Mol. Rec. 10(1997)225]. Two monoclonal autoantibodies,
BV 17-45 and BV 16-13, were extensively studied because of their dual speci
ficity. To quantitatively assess the role of each specificity in the format
ion of stable immune complexes, studies were performed to determine binding
affinities for various sized dsDNA fragments (21, 43, 84, and 114 bp) and
the covalent dimer of a nine amino acid hinge peptide. Results characterizi
ng BV 17-45 showed that the affinity for dsDNA directly correlated with inc
reased dsDNA size. Results with BV 16-13 revealed a generally lower affinit
y for the various dsDNA fragments. Binding inhibition studies, using a cova
lently linked dimer of a nine amino acid synthetic hinge peptide as an inhi
bitor of the antibody-43 bp dsDNA interaction, yielded relative affinities
for the anti-hinge activity. Binding affinities for the synthetic hinge spe
cificity were lower than affinities measured for the anti-dsDNA activity. C
ollectively, the binding and inhibition studies provided insight into the c
orrelation between dual specificity and avid immune complex formation. A mo
del was proposed based on the concept that large dsDNA fragments caused loc
alization of the dual-specific antibodies through the anti-dsDNA activity,
thereby facilitating subsequent binding and cross-linkage via the anti-hing
e specificity. These synergistic interactions resulted in the formation of
avid immune complexes. (C) 2001 Elsevier Science Ltd. All rights reserved.